Abbott receives U.S. FDA clearance for two new over the counter continuous glucose monitoring systems
June 14, 2024- Abbott announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™,…